PuSH - Publikationsserver des Helmholtz Zentrums München: Supporting allergen-specific immunotherapy by inhibition of Janus kinases.

Informationen

Hinweise zu Qualitätskriterien von Zeitschriften

Open-Access-Richtlinie der Helmholtz-Gemeinschaft 2016

CC Licencences

Metriken für Publikationen

Navigation

Startseite

English

EVA: Veröffentlichen

Neuer EVA Antrag

Recherche

Erweiterte Suche

Durchblättern nach ...

... HMGU-Autoren/Konsortien

... Organisationsstruktur

... Zeitschriften

... Publikationstypen

... Forschungsdaten

... Arbeitsgruppen

... Erscheinungsjahr

Publikationen im Überblick

Statistik

HGF Fortschrittsbericht

OA Publikationen

Eintragen

Neue Publikation eintragen

Neue Publikation holen aus...

...EVA

Fehlende Publikation melden

Highlights

Suche

Hilfe & Kontakt

Ansprechpartner

Hilfe

Datenschutz

Helmholtz Open Science

Bibliometrische Indikatoren

SHERPA/RoMEO

DOAJ

Export:

Text

Endnote (RIS) BIB

BibTeX

Gutermuth, J.* ; Schmidt-Weber, C.B. ; Blank, S.

Supporting allergen-specific immunotherapy by inhibition of Janus kinases.

Allergy 74, 1814-1816 (2019)

Postprint

DOI

PMC

	Open Access Green

Abstract
Metriken
Zusatzinfos

Allergen-specific immunotherapy (AIT) is the only disease-modifying and curative treatment for allergic diseases. While in selected indications such as Hymenoptera venom allergy the curative success of AIT is impressingly high, in other disease manifestations it only reduces the symptoms to a certain extend in a fraction of patients. Key problems leading to a reduced efficacy of AIT seem to partly depend on local inflammatory processes that are not only causing side-effects, but additionally feed-back on the specific immune response. Thus, these inflammatory processes also influence the immunologic memory and impair the induction of immune tolerance (1). During the initial phase of AIT, a further increase of Th2 inflammation, including higher levels of allergen-specific IgE has been observed frequently and can be a reason for side-effects and even anaphylactic reactions during AIT.

Altmetric